Challenges to the Paclitaxel/Carboplatin Algorithm in Ovarian Cancer Treatment

被引：0
|
作者：
Zorn, Kristin K. [1 ]
机构：
[1] UPMC, Magee Womens Hosp, Gynecol Canc Program, Pittsburgh, PA USA
来源：
ONCOLOGY-NEW YORK | 2010年 / 24卷 / 08期
关键词：
GYNECOLOGIC-ONCOLOGY-GROUP; CISPLATIN; CYCLOPHOSPHAMIDE; PACLITAXEL; CARCINOMA; TRIAL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：738 / 740
页数：2
相关论文
共 50 条
  • [31] Initial Activation Status of the Antioxidant Response Determines Sensitivity to Carboplatin/Paclitaxel Treatment of Ovarian Cancer
    Pons, Daniel G.
    Sastre-Serra, Jorge
    Nadal-Serrano, Mercedes
    Oliver, Aina
    Garcia-Bonafe, Magdalena
    Bover, Isabel
    Roca, Pilar
    Oliver, Jordi
    ANTICANCER RESEARCH, 2012, 32 (11) : 4723 - 4728
  • [32] Response to Carboplatin and Paclitaxel in the treatment of hereditary breast ovarian cancer syndrome (HBOC): a case report
    Mehmood, Faisal
    Touseef, Mumtaz
    Ashraf, Amna
    Rai, Izza Ali
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2024, 74 (12) : 2184 - 2187
  • [33] Paclitaxel (Taxol(R)) plus carboplatin as first-line treatment for advanced ovarian cancer
    Ozols, RF
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1996, 6 : 9 - 12
  • [34] Gemcitabine and carboplatin treatment in Patients with relapsing ovarian cancer
    Sufliarsky, J.
    Chovanec, J.
    Svetlovska, D.
    Minarik, T.
    Packan, T.
    Kroslakova, D.
    Lalabova, R.
    Helpianska, L.
    Horvathova, D.
    Sevcik, L.
    Spacek, J.
    Laluha, A.
    Tkacova, V.
    Malec, V.
    Rakicka, G.
    Magdin, D.
    Jancokova, I.
    Dorr, A.
    Stresko, M.
    Habetinek, V.
    Koza, I.
    NEOPLASMA, 2009, 56 (04) : 291 - 297
  • [35] A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancer
    Eisenhauer, Eric L.
    Zanagnolo, Vanna
    Cohn, David E.
    Salani, Ritu
    O'Malley, David M.
    Sutton, Gregory
    Callahan, Michael J.
    Cobb, Bobbi
    Fowler, Jeffrey M.
    Copeland, Larry J.
    GYNECOLOGIC ONCOLOGY, 2014, 134 (02) : 262 - 266
  • [36] Comparison of the Short term Efficacy and Serum Markers between Lobaplatin/Paclitaxel and Carboplatin/Paclitaxel-based Adjuvant Chemotherapy in Patients with Ovarian Cancer
    Li, Zhihui
    Chen, Ying
    Zhang, Shihong
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 82 : 23 - 29
  • [37] Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer
    du Bois, Andreas
    Herrstedt, Jorn
    Hardy-Bessard, Anne-Claire
    Mueller, Hans-Helge
    Harter, Philipp
    Kristensen, Gunnar
    Joly, Florence
    Huober, Jens
    Avall-Lundqvist, Elisabeth
    Weber, Beatrice
    Kurzeder, Christian
    Jelic, Svetislav
    Pujade-Lauraine, Eric
    Burges, Alexander
    Pfisterer, Jacobus
    Gropp, Martina
    Staehle, Anne
    Wimberger, Pauline
    Jackisch, Christian
    Sehouli, Jalid
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (27) : 4162 - 4169
  • [38] Bevacizumab, paclitaxel and carboplatin for advanced ovarian cancer: low risk of gastrointestinal and cardiovascular toxicity
    Abaid, L. N.
    Lopez, K. L.
    Micha, J. P.
    Rettenmaier, M. A.
    Brown, J. V., III
    Goldstein, B. H.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2010, 31 (03) : 308 - 311
  • [39] Combination Chemotherapy with Carboplatin and Paclitaxel for Advanced Thymic Cancer
    Furugen, Makoto
    Sekine, Ikuo
    Tsuta, Koji
    Horinouchi, Hidehito
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Kubota, Kaoru
    Tamura, Tomohide
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (08) : 1013 - 1016
  • [40] Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study
    Kurtz, J. E.
    Kaminsky, M. C.
    Floquet, A.
    Veillard, A. S.
    Kimmig, R.
    Dorum, A.
    Elit, L.
    Buck, M.
    Petru, E.
    Reed, N.
    Scambia, G.
    Varsellona, N.
    Brown, C.
    Pujade-Lauraine, E.
    ANNALS OF ONCOLOGY, 2011, 22 (11) : 2417 - 2423
12345